Stem cell transplantation in follicular lymphoma: progress at last? Bone Marrow Transplant 2004; 34(11): 929-938.Tse WW,Lazarus HM,Van Besien K. Stem cell transplantation in follicular lymphoma:progress at last?[J].Bone Marrow Transplantation,2004,(11):929-38.doi:10.1038/sj.bmt.1704654....
Long-term outcomes are poor when patients with relapsed/refractory lymphoma do not have a complete response to chemotherapy before stem cell transplant. In clinical trials of anti-CD30 CAR T-cells in relapsed/refractory disease, the overall response rates are 53% to 78%, and the median progress...
Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.[J].Bone marrow transplantation 2002,Suppl.1(Suppl.1).Gianni AM, Cortelazzo S, Magni M, Martelli M. Rituximab: enhancing stem cell transplantation in mantle cell lymphoma. Bone Marrow Transplant 2002; 29 Suppl 1: S10-3....
Stem cell transplantation(SCT) is an important therapeutic intervention for the treatment of a variety of hematologic cancers including leukemia, lymphoma, myeloma, myleodysplastic syndromes, and bone marrow failure states.1–5In this procedure hematopoietic cells are collected either from a donor (...
stem cell transplantationclinical trialsMantle cell lymphoma (MCL) is an aggressive form of non‐Hodgkin lymphoma that remains incurable for the majority of patients. Allogeneic stem cell transplantation (alloSCT) produces long‐term disease‐free remissions for around 30–40% patients, however it is...
Non Hodgkins Lymphoma Treatment High Dose Therapy and Stem Cell Transplant for Treatment of Mantle Cell Lymphoma Research reports on autologous & allogeneic stem cell transplant for newly diagnosed and recurrent mantle cell lymphoma. By Dr. C.H. Weaver M.D.Feb 6, 2023 Read More ...
Allogeneic hematopoietic cell transplantation (allo-HCT), via its immunologic graft-versus-lymphoma effect, has been used to salvage patients with relapsed or refractory disease, resulting in long-term disease-free survival in a fraction of patients. However, the higher risk of transplant-related ...
The aim of this prospective phase II trial was to determine the safety and efficacy of a nonmyeloablative conditioning program incorporating peritransplant rituximab in patients with CD20+ B cell non-Hodgkin lymphoma (B-NHL) receiving an allogeneic stem cell transplant (allo-SCT). Fifty-one adult...
(HealthDay)—For patients with refractory or relapsed peripheral T-cell lymphoma (R/R-PTCL), three- and five-year overall survival (OS) and progression-free survival (PFS) are similar with allogeneic or autologous hematopoietic stem cell transplant (HSCT
- 《Biol Blood Marrow Transplant》 被引量: 219发表: 2009年 Hematopoietic Stem Cell Transplantation for Cutaneous T-Cell Lymphoma Extranodal natural killer (NK)/T cell lymphoma, nasal type, is a recently recognized distinct entity and the most common type of non鈥揃 cell extranodal ly... ...